Earnings call transcript: Amentum Holdings beats Q2 2026 EPS forecast, stock dips

Amentum reported Q2 FY2026 EPS of $0.60 versus $0.37 expected, a 62.2% beat, while revenue rose 3% year over year to $3.5 billion. Adjusted EBITDA increased to $275 million with a 7.9% margin, free cash flow was $220 million, and the company reaffirmed FY2026 guidance. Despite the strong print, shares fell 0.9% after hours, reflecting some investor caution even as bookings, backlog, and new contract awards remained very strong.

Analysis

The market is treating this as a quality-confirmation event, but the more interesting signal is that bookings and backlog are now doing the heavy lifting just as margin expansion becomes visibly self-funded. That combination matters because it reduces the company’s dependence on any single budget cycle and makes the equity less about one-quarter earnings beats and more about the durability of the 2027-28 growth path. The immediate beneficiaries are the adjacent private-capex and mission-critical infrastructure ecosystems: telecom, data center retrofit, nuclear supply chain, and security software vendors that can ride Amentum’s broader project funnel.

The second-order read-through is that Amentum is increasingly behaving like a “picks-and-shovels” proxy for AI infrastructure and defense modernization, but with a government-services cash engine underneath. That mix should compress perceived cyclicality over time and justify a higher multiple if execution holds, because the market typically pays up for contractors that can show secular growth plus margin improvement without needing acquisitions. The underappreciated risk is that the current valuation may already be discounting a smooth conversion of backlog into revenue; any slippage in program starts, JV transition friction, or NASA-related revenue bleed would hit sentiment quickly because the stock has not yet re-rated to a true growth multiple.

Near-term, the stock reaction suggests investors are skeptical that strong fundamentals translate into near-term upside, which creates an opportunity if the next catalyst sequence stays intact: guidepost quarters, award cadence, and leverage moving through the high-twos. The contrarian miss is that the market may be underestimating how much of the upside is now coming from mix shift rather than top-line acceleration, which tends to show up gradually over the next 2-4 quarters, not immediately. In other words, this is less a “beat-and-raise” story than a multiple-expansion setup if management can keep proving that higher-quality work is replacing lower-quality revenue.

Key Decisions for Investors

• Go long AMTM on a 2-4 week horizon via equity or a call spread; use the post-earnings dip as entry, targeting a re-rating if the next awards tranche confirms backlog conversion. Risk: a 5-8% drawdown if the market stays focused on muted reported growth rather than mix improvement.
• Pair trade: long AMTM / short a more budget-sensitive government-services peer basket over 1-3 months, expecting AMTM’s exposure to AI infrastructure, nuclear, and higher-margin fixed-price work to outperform in a slowing macro tape.
• Buy AMTM Jan-2027 calls or call spreads if available liquidity is sufficient; this is a 6-12 month thesis on backlog-to-revenue conversion plus leverage reduction creating a cleaner equity story. Risk/reward improves if net leverage approaches sub-3x as guided.
• For event-driven desks, buy dips only after award visibility updates, not into the first pop; the best entry is likely after a pause if the market waits for proof that FY27 growth is not merely backlog optics.
• Hedge downside with a tight stop or short-dated puts around any guidance reset risk, especially tied to NASA insourcing or JV transition noise; those are the fastest ways to break the multi-quarter bull case.